Navigation Links
Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy
Date:12/6/2008

s operations are described under 'Risk Factors' in the 'Business Review' in the company' s Annual Report on Form 20-F for 2007.

Valeant Pharmaceuticals forward-looking statements

This press release contains forward-looking statements, including, but not limited to, statements regarding expectations or plans of development program for retigabine and the potential role retigabine could play in managing epilepsy and in treating other indications, and the commercial opportunity retigabine may present for Valeant. These statements are based upon the current expectations and beliefs of Valeant's management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties related to the clinical development of retigabine, the fact that adverse events are not always immediately apparent even in well designed clinical trials, regulatory approval processes, the potential that competitors may bring to market drugs or treatments that are more effective of more commercially attractive than retigabine, and other risks and uncertainties discussed in the company's filings with the SEC. Valeant wishes to caution the reader that these factors are among the factors that could cause actual results to differ materially from the expectations described in the forward- looking statements. Valeant also cautions the reader that undue reliance should not be placed on any of the forward-looking statements, which speak only as of the date of this release. The company undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this release or to reflect actual outcomes.

    Registered in England & Wales:
    No. 3888792

    Registered Office:
    980 Great West Road
    Brentfo
'/>"/>
SOURCE GlaxoSmithKline; Valeant Pharmaceuticals International
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome
2. GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP
3. Study Showed Prevention of Heart Attacks Within Three Months After Hospitalization Significantly Averted Future Heart Attacks and Death
4. Study Suggests Treatment with Paliperidone ER Significantly Improves Symptoms of Schizoaffective Disorder
5. ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments
6. Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD
7. Successful Results for Mymetics Corporations Mucosal HIV/AIDS Vaccine Viral Challenge Significantly Exceeds Expectations
8. Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel
9. Hibernation-On-Demand Drug Hydrogen Sulfide Significantly Improves Survival After Extreme Blood Loss
10. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
11. New Study: Pine Bark Significantly Reduces Menstrual Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014 The National Necrotizing ... Fernando Davila has been successfully treated for a life ... Dr, Anibal R. Gauto , Medical Director of Inpatient ... Eisenhower Medical Center in Rancho Mirage, California ... pioneered by Dr. John Crew at Seton Hospital ...
(Date:8/20/2014)...   Ventana Medical Systems, Inc.  (Ventana), a ... its VENTANA System for Primary Diagnosis 1 ... for routine pathology, including primary diagnosis with human ... software coupled with either the VENTANA iScan Coreo ... automated digital slide creation, case management and computer ...
(Date:8/20/2014)... , Aug. 20, 2014 ApolloDx™ today announced ... platform during a special event at the company,s office ... on September 5, 2014. The event, which will start ... ApolloDx website, www.apollodx.com .    "We ... said Jared Bauer , Co-Founder and Managing Partner ...
Breaking Medicine Technology:Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 2Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 3Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 4Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 5Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 6Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 2Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 3
... Despite a fragile economy, America,s pharmaceutical research and biotechnology companies invested a record $65.3 billion ... than $1.5 billion from 2008, according to analyses by the Pharmaceutical Research and Manufacturers of America ... ... , ...
... , NATICK, Mass. and ATLANTA , ... BSX ) today announced results from an ... trial assessing the impact of diabetes on clinical and ... TAXUS® Express2™ Paclitaxel-Eluting Stent System or the ...
Cached Medicine Technology:R&D Investment by U.S. Biopharmaceutical Companies Remains Strong Despite Ongoing Economic Challenges 2R&D Investment by U.S. Biopharmaceutical Companies Remains Strong Despite Ongoing Economic Challenges 3R&D Investment by U.S. Biopharmaceutical Companies Remains Strong Despite Ongoing Economic Challenges 4R&D Investment by U.S. Biopharmaceutical Companies Remains Strong Despite Ongoing Economic Challenges 5R&D Investment by U.S. Biopharmaceutical Companies Remains Strong Despite Ongoing Economic Challenges 6Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents at One Year Compared to Bare-Metal Stents in Diabetic Patients Experiencing Heart Attack 2Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents at One Year Compared to Bare-Metal Stents in Diabetic Patients Experiencing Heart Attack 3Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents at One Year Compared to Bare-Metal Stents in Diabetic Patients Experiencing Heart Attack 4Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents at One Year Compared to Bare-Metal Stents in Diabetic Patients Experiencing Heart Attack 5Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents at One Year Compared to Bare-Metal Stents in Diabetic Patients Experiencing Heart Attack 6
(Date:8/21/2014)... 21, 2014 Only 20 percent of healthcare ... Affordable Care Act according to a new report . ... responding to a request from Smart Data pioneer ... lead providers to violate privacy laws in many states. , ... many hospitals and clinics are failing to do so in ...
(Date:8/21/2014)... 21, 2014 Inc. magazine ranked Centurion ... 500|5000, an exclusive ranking of the nation's fastest-growing private ... the most important segment of the economy—America’s independent entrepreneurs. ... LinkedIn, Zillow, and many other well-known names gained early ... is proud to have been named to the Inc. ...
(Date:8/21/2014)... Houston, TX (PRWEB) August 21, 2014 Sometimes you ... destiny. , In his new book “From Zero to a Hundred: ... police officer, shares his story of surviving a broken family, a ... “Adversity brings affirmation of who you were created to be,” Roy ... zero,’ which is why I know my purpose today of helping ...
(Date:8/21/2014)... CQIIP, Continuous Quality Immunization Improvement ... Control and Prevention and the Department of Defense. ... the immunization standards and are administered in accordance ... on Immunizations. , ACC chose to adopt the ... place to protect patients, improve efficiency, and increase ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 ... aging interventions and addressing the challenges of ... concept, OncoFinder, for signalome-wide pathway analysis. ... robust cross-platform analysis of gene expression data ... research, published in the journal Frontiers in ...
Breaking Medicine News(10 mins):Health News:Report: Only 20 Percent of Healthcare Providers Meet ACA Requirement 2Health News:Centurion Service Group Named to Inc. Magazine's List of the Nation's Fastest-Growing Private Companies 2Health News:Centurion Service Group Named to Inc. Magazine's List of the Nation's Fastest-Growing Private Companies 3Health News:Centurion Service Group Named to Inc. Magazine's List of the Nation's Fastest-Growing Private Companies 4Health News:Zero to a Hundred: True Story of Escaping Death to Meet Life 2Health News:ACC Health Raises the Bar Again by Completing the CQIIP Certification Program 2Health News:OncoFinder, a new algorithm for minimizing errors in high-throughput transcriptome analysis 2
... JUPITER, FL, May 28, 2009 Current tests to identify specific ... diseases (such as mad cow) in animals and humans, can ... results a time-lag that may put human populations at ... Research Institute,s Florida campus have developed a new method that ...
... Inc. (NYSE: DVA ) announced today ... the Company,s Board of Directors. (Logo: ... former President of American Express International, Japan, Asia-Pacific, ... the Consumer Card business across 12 countries, heading ...
... Annoying seasonal allergies is now a year round threat. ... to nest in the home. Indoor air pollution is ... chemicals, synthetic materials and impurities. To expel these year ... to home ventilation and eliminates allergens.The EZ Breathe system ...
... The best respiratory protection is useless if it ... series, Draeger dedicated special attention to ensuring that the ... comfort of the wearer was maximized. While offering extremely ... been compromised. (Photo: http://www.newscom.com/cgi-bin/prnh/20090528/NE24067 ...
... Darwin National,Assurance Company, a member company of Allied ... ), today announced that Becky Cox has been ... Ms. Cox will,be responsible for the continued development ... Fred Bautista, Vice,President, Business Development, Healthcare. , ...
... of overdose, and potential liver damage, is still too ... -- One month after mandating stricter warning labels about ... U.S. regulators are contemplating even tougher standards. , Advisers ... late next month to review a new agency report ...
Cached Medicine News:Health News:Scripps Florida scientists devise accelerated method to determine infectious prion strains 2Health News:Scripps Florida scientists devise accelerated method to determine infectious prion strains 3Health News:Pamela M. Arway Joins DaVita Board of Directors 2Health News:EZ Breathe(R) Home Ventilation System Expels Allergens, Moisture and Smells 2Health News:Comfort Matters - The new Draeger Series of Filtering Facepiece Respirators Demonstrate Exceptional Wearer Comfort 2Health News:Darwin Appoints Becky Cox Vice President, Business Development, Healthcare 2Health News:Darwin Appoints Becky Cox Vice President, Business Development, Healthcare 3Health News:FDA Report Urges Tougher Acetaminophen Warning 2
... Solution is the ... povidone-iodine. It is a ... kills gram-positive and gram-negative ... organisms), as well as ...
... Aplicare's disposable 1-ounce pouches are designed for ... waste. They are used in nursing homes, ... rooms and many other hospital departments. This ... is a mild antiseptic, germicidal and cleansing ...
... Aplicare's Iodine Scrub is a gentle ... formulated to prevent dryness. Povidone Iodine is ... gram-negative and gram-positive bacteria, fungi, viruses, protozoa ... lather; the first step in patient pre-operative ...
... Iodine Scrub is a gentle and effective ... prevent dryness. Povidone Iodine is known to ... gram-positive bacteria, fungi, viruses, protozoa and yeasts. ... first step in patient pre-operative prepping, as ...
Medicine Products: